Adam Stefański
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diabetes Treatment and Management 22
- Diabetes Management and Research 3
- Nephrology 10
- Parathyroid Disorders and Treatments 5
- Co-authors
- Nadia N. AhmadMathijs C. BunckSean WhartonLouis J. AronneShuyu ZhangAnia M. JastreboffLisa ConneryBing Liu
- Journals
- Diabetes Obesity and Metabolism (9 papers)Diabetes (4 papers)Circulation (3 papers)Endocrine Practice (3 papers)Journal of the American Society of Nephrology (3 papers)
- Partner nations
- United StatesPolandCanada
In The Last Decade
Adam Stefański
59 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 1.5k
- Pharmacology 932
- Nephrology 341
- Physiology 883
- Endocrine and Autonomic Systems 160
Countries citing papers authored by Adam Stefański
This map shows the geographic impact of Adam Stefański's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Stefański with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Stefański more than expected).
Fields of papers citing papers by Adam Stefański
This network shows the impact of papers produced by Adam Stefański. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Stefański. The network helps show where Adam Stefański may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam Stefański, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | Body composition changes during weight reduction with tirzepatide in the Hit paper breakdown → | 2025 | 21 |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2025 | 3 | |
| 7 | 2025 | 10 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 1 | |
| 10 | 2024 | 2 | |
| 11 | 2024 | 15 | |
| 12 | Tirzepatide for Obesity Treatment and Diabetes Prevention Hit paper breakdown → | 2024 | 133 |
| 13 | 2024 | 18 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 25 | |
| 16 | 2023 | 25 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 4 | |
| 19 | [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?]. | 2008 | 1 |
| 20 | [Diabetes control in type 2 diabetic subjects treated in primary health care]. | 2006 | 2 |
About Adam Stefański
Adam Stefański is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Pharmacology, Physiology and Complementary and Manual Therapy, having authored 64 papers that have together received 2.9k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (22 papers), Pharmacology and Obesity Treatment (21 papers), Diet and metabolism studies (17 papers), Metabolism, Diabetes, and Cancer (13 papers), Parathyroid Disorders and Treatments (5 papers), Adipose Tissue and Metabolism (5 papers), Cardiovascular Function and Risk Factors (3 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Pharmacology (932 citations), Nephrology (341 citations), Physiology (883 citations) and Endocrine and Autonomic Systems (160 citations). Adam Stefański has collaborated with scholars based in United States, Poland and Canada. Frequent co-authors include Nadia N. Ahmad, Mathijs C. Bunck, Sean Wharton, Louis J. Aronne, Shuyu Zhang, Ania M. Jastreboff, Lisa Connery, Bing Liu, Breno Edson Sendão Alves and Eberhard Ritz. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Circulation, Endocrine Practice and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.